Home › Funds › Vontobel Holding Ltd. › ABT
Vontobel Holding Ltd. position in ABT
ABBOTT LABORATORIES · Health Care
Vontobel Holding Ltd. reported holding 884,233 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$80.2M, representing 0.49% of its reported portfolio and ranking #50 among its reported holdings. Vontobel Holding Ltd. first reported this position in Q2 2026.
How Vontobel Holding Ltd.'s ABT position evolved
Vontobel Holding Ltd. first disclosed a stake in ABT in Q2 2026 at 884,233 shares (US$80.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 884.23K | $80.24M | New |
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 215 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), BlackRock Inc (US$13.84B), VANGUARD CAPITAL MANAGEMENT LLC (US$10.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- BlackRock Inc 152.56M sh · $13.84B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 113.75M sh · $10.32B · Q2 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 49.02M sh · $4.45B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 39.22M sh · $3.54B · Q2 2026
- Geode Capital Management 39.22M sh · $3.54B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026